21-46418215-C-T

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BS1BS2

The NM_006031.6(PCNT):​c.6933C>T​(p.Val2311Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00287 in 1,587,530 control chromosomes in the GnomAD database, including 27 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0030 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0029 ( 27 hom. )

Consequence

PCNT
NM_006031.6 synonymous

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:6

Conservation

PhyloP100: -1.02

Publications

3 publications found
Variant links:
Genes affected
PCNT (HGNC:16068): (pericentrin) The protein encoded by this gene binds to calmodulin and is expressed in the centrosome. It is an integral component of the pericentriolar material (PCM). The protein contains a series of coiled-coil domains and a highly conserved PCM targeting motif called the PACT domain near its C-terminus. The protein interacts with the microtubule nucleation component gamma-tubulin and is likely important to normal functioning of the centrosomes, cytoskeleton, and cell-cycle progression. Mutations in this gene cause Seckel syndrome-4 and microcephalic osteodysplastic primordial dwarfism type II. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015]
PCNT Gene-Disease associations (from GenCC):
  • microcephalic osteodysplastic primordial dwarfism type II
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • Moyamoya disease
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.65).
BP6
Variant 21-46418215-C-T is Benign according to our data. Variant chr21-46418215-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 211876.
BP7
Synonymous conserved (PhyloP=-1.02 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00295 (449/151972) while in subpopulation SAS AF = 0.00581 (28/4818). AF 95% confidence interval is 0.00413. There are 0 homozygotes in GnomAd4. There are 258 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 27 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PCNTNM_006031.6 linkc.6933C>T p.Val2311Val synonymous_variant Exon 31 of 47 ENST00000359568.10 NP_006022.3
PCNTNM_001315529.2 linkc.6579C>T p.Val2193Val synonymous_variant Exon 31 of 47 NP_001302458.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PCNTENST00000359568.10 linkc.6933C>T p.Val2311Val synonymous_variant Exon 31 of 47 1 NM_006031.6 ENSP00000352572.5

Frequencies

GnomAD3 genomes
AF:
0.00292
AC:
444
AN:
151854
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00134
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00151
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00581
Gnomad FIN
AF:
0.0119
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00301
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.00372
AC:
935
AN:
251110
AF XY:
0.00423
show subpopulations
Gnomad AFR exome
AF:
0.00118
Gnomad AMR exome
AF:
0.00182
Gnomad ASJ exome
AF:
0.000199
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.0133
Gnomad NFE exome
AF:
0.00268
Gnomad OTH exome
AF:
0.00261
GnomAD4 exome
AF:
0.00286
AC:
4112
AN:
1435558
Hom.:
27
Cov.:
28
AF XY:
0.00319
AC XY:
2282
AN XY:
716150
show subpopulations
African (AFR)
AF:
0.000775
AC:
25
AN:
32276
American (AMR)
AF:
0.00193
AC:
86
AN:
44660
Ashkenazi Jewish (ASJ)
AF:
0.000116
AC:
3
AN:
25942
East Asian (EAS)
AF:
0.0000505
AC:
2
AN:
39584
South Asian (SAS)
AF:
0.00809
AC:
693
AN:
85690
European-Finnish (FIN)
AF:
0.0131
AC:
702
AN:
53392
Middle Eastern (MID)
AF:
0.00280
AC:
16
AN:
5720
European-Non Finnish (NFE)
AF:
0.00219
AC:
2389
AN:
1088876
Other (OTH)
AF:
0.00330
AC:
196
AN:
59418
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.440
Heterozygous variant carriers
0
190
379
569
758
948
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
94
188
282
376
470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00295
AC:
449
AN:
151972
Hom.:
0
Cov.:
33
AF XY:
0.00347
AC XY:
258
AN XY:
74282
show subpopulations
African (AFR)
AF:
0.00145
AC:
60
AN:
41320
American (AMR)
AF:
0.00150
AC:
23
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5186
South Asian (SAS)
AF:
0.00581
AC:
28
AN:
4818
European-Finnish (FIN)
AF:
0.0119
AC:
126
AN:
10574
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00301
AC:
205
AN:
67994
Other (OTH)
AF:
0.00237
AC:
5
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
23
46
70
93
116
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00227
Hom.:
0
Bravo
AF:
0.00171
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00262
EpiControl
AF:
0.00267

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:6
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:3
May 02, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PCNT: BP4, BP7, BS2 -

Microcephalic osteodysplastic primordial dwarfism type II Benign:2
Jun 22, 2020
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

not specified Uncertain:1
Oct 21, 2014
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

PCNT-related disorder Benign:1
Jun 10, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.65
CADD
Benign
0.62
DANN
Benign
0.83
PhyloP100
-1.0
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs148444313; hg19: chr21-47838129; API